A 6-month depot formulation of leuprolide acetate is safe and effective in daily clinical practice: a non-interventional prospective study in 1273 patients

BACKGROUND: Testosterone stimulates growth in many prostate tumours. The established GnRH analogue leuprolide acetate is incorporated in a novel biodegradable polymer matrix (Atrigel(® )delivery system), that can be administered to reduce testosterone levels in men with advanced hormone-dependent pr...

Descripción completa

Detalles Bibliográficos
Autor principal: Tunn, Ulf W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161957/
https://www.ncbi.nlm.nih.gov/pubmed/21801354
http://dx.doi.org/10.1186/1471-2490-11-15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161957/
https://www.ncbi.nlm.nih.gov/pubmed/21801354
http://dx.doi.org/10.1186/1471-2490-11-15

Ejemplares similares